Product logins

Find logins to all Clarivate products below.


Coronary Artery Bypass Graft Devices – Market Insights – United States

The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option. Favorable clinical evidence, particularly in favor of CABG in complex disease, will help stabilize surgical referral patterns despite continued PCI adoption.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for CABG devices in the US, with market projections from 2019 through 2034.

The increasing prevalence of complex CAD cases will drive demand for CABG procedures.

How does procedure preference between CABG surgery and PCI differ by treatment complexity in the US?

What are the key preferences of physicians when selecting CABG devices?

Recent regulatory actions and recalls are influencing purchasing decisions in the CABG device market.

How are recent recalls and FDA safety communications shaping competitive dynamics within the US CABG device market?

Which of the CABG device segments are most impacted by heightened quality scrutiny?

Price competition will limit revenue growth potential, especially in light of increased cost-consciousness among healthcare facilities.

Which segments will experience the most price competition?

What strategies can CABG device manufacturers adapt to address the increasing cost-consciousness among healthcare facilities?

Table of contents


Related Medtech Insights Reports

Report
Dental CAD/CAM Systems – Market Insights – Global
The dental CAD/CAM system market continues to evolve as manufacturers introduce more advanced design tools, increasingly integrated digital workflows, and closer connections to adjunct technologies…
Report
Biosurgical Agents – Market Insights – US
The biosurgical agent market in the US will experience modest growth through 2034. This growth will be fueled by rising surgical procedure volumes that require biosurgical agent and strong…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…